Search Results - "KAWAZOE, Hitoshi"

A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin‐Based Chemotherapy‐Induced Nausea and Vomiting in Japan by Iihara, Hirotoshi, Shimokawa, Mototsugu, Hayashi, Toshinobu, Kawazoe, Hitoshi, Saeki, Toshiaki, Aiba, Keisuke, Tamura, Kazuo

“…Background We previously reported the results of a prospective study of chemotherapy‐induced nausea and vomiting (CINV) in a cohort of patients who received…”
Get full text

Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study by Kitazume, Yoshiko, Kawazoe, Hitoshi, Uozumi, Ryuji, Yoshizawa, Tomoe, Iihara, Hirotoshi, Fujii, Hironori, Takahashi, Masaya, Arai, Takahiro, Murachi, Yasushi, Sato, Yumiko, Mikami, Takahiro, Hashiguchi, Koji, Yamazaki, Tomoko, Takahashi, Katsuyuki, Fujita, Yukiyoshi, Hosokawa, Yuki, Morozumi, Issei, Tsuchiya, Masami, Yokoyama, Atsushi, Hashimoto, Hironobu, Yamaguchi, Masakazu

“…The association between capecitabine efficacy and proton pump inhibitors (PPIs) is controversial. Here, we determined whether co-administration of PPIs affects…”
Get full text

Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents by Kikuyama, Fumihiro, Suzuki, Sayo, Jibiki, Aya, Yokoyama, Yuta, Kawazoe, Hitoshi, Kitanaka, Susumu, Nakamura, Tomonori

“…Pancreatic cancer is associated with a poor prognosis; thus, there is an urgent need to develop new and effective treatments. Ingenol mebutate (IM), which is…”
Get full text

Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation by Uchida, Mami, Ushio, Soichiro, Niimura, Takahiro, Takechi, Kenshi, Kawazoe, Hitoshi, Hidaka, Noriaki, Tanaka, Akihiro, Araki, Hiroaki, Zamami, Yoshito, Ishizawa, Keisuke, Kitamura, Yoshihisa, Sendou, Toshiaki, Kawasaki, Hiromu, Namba, Hiroyuki, Shibata, Kazuhiko, Tanaka, Mamoru, Takatori, Shingo

“…Oxaliplatin (OXA) is used in chemotherapy for various cancer types and is associated with acute and chronic neurotoxicity. However, a preventive strategy for…”
Get full text

Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study by Tashiro, Ryota, Kawazoe, Hitoshi, Mamishin, Kanako, Seto, Keisuke, Udagawa, Ryoko, Saito, Yoshimasa, Hashimoto, Hironobu, Shimoi, Tatsunori, Yonemori, Kan, Yonemura, Masahito, Terakado, Hiroyuki, Nishimura, Takahiro, Kawasaki, Toshikatsu, Furukawa, Tetsuya, Nakamura, Tomonori

“…The standard treatment for platinum-sensitive relapsed ovarian cancer (PSROC) is platinum-based chemotherapy followed by olaparib monotherapy. A retrospective…”
Get full text

Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum by Ishikawa, Emi, Yokoyama, Yuta, Chishima, Haruna, Kuniyoshi, Ouki, Sato, Itaru, Nakaya, Naoki, Nakajima, Hideo, Kimura, Motonori, Hakamata, Jun, Suehiro, Naoya, Nakada, Hideo, Ikemura, Shinnosuke, Jibiki, Aya, Kawazoe, Hitoshi, Muramatsu, Hiroshi, Suzuki, Sayo, Nakamura, Tomonori

“…•A novel method for therapeutic drug monitoring of newer generation EGFR-TKIs.•Simultaneous quantification of parent compounds and active metabolites of…”
Get full text

Preventive Effects of Renin-angiotensin System Inhibitors on Oxaliplatin-induced Peripheral Neuropathy: A Retrospective Observational Study by Uchida, Mami, Kawazoe, Hitoshi, Takatori, Shingo, Namba, Hiroyuki, Uozumi, Ryuji, Tanaka, Akihiro, Kawasaki, Hiromu, Araki, Hiroaki

“…Oxaliplatin-induced peripheral neuropathy has remained an unresolved issue in clinical practice. Our previous study hypothesized that inhibition of the…”
Get full text

Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis by Yamamoto, Senri, Iihara, Hirotoshi, Uozumi, Ryuji, Kawazoe, Hitoshi, Tanaka, Kazuki, Fujita, Yukiyoshi, Abe, Masakazu, Imai, Hisao, Karayama, Masato, Hayasaki, Yoh, Hirose, Chiemi, Suda, Takafumi, Nakamura, Kazuto, Suzuki, Akio, Ohno, Yasushi, Morishige, Ken-Ichirou, Inui, Naoki

“…Olanzapine has been reported to be an effective antiemetic in patients receiving carboplatin-based chemotherapy. However, the efficacy of a neurokinin-1…”
Get full text

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study by Egami, Saeka, Kawazoe, Hitoshi, Hashimoto, Hironobu, Uozumi, Ryuji, Arami, Toko, Sakiyama, Naomi, Ohe, Yuichiro, Nakada, Hideo, Aomori, Tohru, Ikemura, Shinnosuke, Fukunaga, Koichi, Yamaguchi, Masakazu, Nakamura, Tomonori

“…Among patients with advanced non-small-cell lung cancer who were treated with nivolumab monotherapy, the association of peripheral blood count data (at…”
Get full text

Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials by Yamamoto, Senri, Iihara, Hirotoshi, Uozumi, Ryuji, Kawazoe, Hitoshi, Tanaka, Kazuki, Fujita, Yukiyoshi, Abe, Masakazu, Imai, Hisao, Karayama, Masato, Hayasaki, Yoh, Hirose, Chiemi, Suda, Takafumi, Nakamura, Kazuto, Suzuki, Akio, Ohno, Yasushi, Morishige, Ken-ichirou, Inui, Naoki

“…Background The efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on…”
Get full text

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study by Tashiro, Ryota, Kawazoe, Hitoshi, Mamishin, Kanako, Seto, Keisuke, Udagawa, Ryoko, Saito, Yoshimasa, Hashimoto, Hironobu, Shimoi, Tatsunori, Yonemori, Kan, Yonemura, Masahito, Terakado, Hiroyuki, Kawasaki, Toshikatsu, Furukawa, Tetsuya, Nakamura, Tomonori

“…BackgroundOlaparib-induced anemia is a frequently occurring complication in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal…”
Get full text

Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study by Kawazoe, Hitoshi, Yano, Akiko, Ishida, Yuri, Takechi, Kenshi, Katayama, Hitoshi, Ito, Ryoji, Yakushijin, Yoshihiro, Moriguchi, Toshihide, Tanaka, Mamoru, Tanaka, Akihiro, Araki, Hiroaki

“…As the major toxicity induced by pemetrexed plus carboplatin is severe hematologic toxicities, the aim of this study was to determine the risk factors for…”
Get full text

Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders by Takechi, Kenshi, Yoshioka, Yurika, Kawazoe, Hitoshi, Tanaka, Mamoru, Takatori, Shingo, Kobayashi, Miwako, Matsuoka, Ichiro, Yanagawa, Hiroaki, Zamami, Yoshito, Imanishi, Masaki, Ishizawa, Keisuke, Tanaka, Akihiro, Araki, Hiroaki

“…Treatment with antipsychotic drugs has been associated with hyperprolactinemia. The same antipsychotic drugs have also been associated with side effects such…”
Get full text

Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B) by Ozeki, Rie, Iihara, Hirotoshi, Shimokawa, Mototsugu, Hashimoto, Hironobu, Abe, Masakazu, Mukohara, Toru, Bando, Hiroko, Hayashi, Toshinobu, Kawazoe, Hitoshi, Komoda, Masayo, Yanai Takahashi, Takako, Saito, Mitsue

“…IntroductionTriple antiemetic therapy with neurokinin-1 receptor antagonist, 5-hydroxytryptamine type 3 receptor antagonist, and dexamethasone has been widely…”
Get full text

Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study by Ogiwara, Toshiki, Kawazoe, Hitoshi, Egami, Saeka, Hashimoto, Hironobu, Saito, Yoshimasa, Sakiyama, Naomi, Ohe, Yuichiro, Yamaguchi, Masakazu, Furukawa, Tetsuya, Hara, Azusa, Hiraga, Yui, Jibiki, Aya, Yokoyama, Yuta, Suzuki, Sayo, Nakamura, Tomonori

“…Nivolumab and pembrolizumab are the standard treatments for patients with advanced non-small-cell lung cancer (NSCLC). While there are reports on several…”
Get full text

Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study by Yokokawa, Takashi, Suzuki, Kenichi, Tsuji, Daiki, Hosonaga, Mari, Kobayashi, Kazuo, Kawakami, Kazuyoshi, Kawazoe, Hitoshi, Nakamura, Tomonori, Suzuki, Wataru, Sugisaki, Takahito, Aoyama, Takeshi, Hashimoto, Koki, Hatori, Masahiro, Tomomatsu, Takuya, Inoue, Ayaka, Azuma, Keiichi, Asano, Maimi, Takano, Toshimi, Ohno, Shinji, Yamaguchi, Masakazu

“…Background Female sex and younger age are reported risk factors for chemotherapy‐induced nausea and vomiting (CINV) in highly emetogenic chemotherapy, but the…”
Get full text

病院薬剤師のキャリアビジョンに対する意識調査 by 河添, 仁, 土屋, 雅美, 藤堂, 真紀, 原, 梓, 大西, 友美子, 大里, 洋一, 堀, 里子

“…「緒言」これまでの日本医療薬学会年会では薬剤師のキャリア形成に関連するシンポジウムはほとんどなかった. 近年, 2020年に1題, 2021年に2題, 2022年に3題とキャリア形成に関連するシンポジウム採択数が増加している. すなわち, 男女共同参画,…”
Get full text

Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain by Kawazoe, Hitoshi, Sumikawa, Satomi, Nakauchi, Kana, Yakushijin, Yoshihiro, Yamamoto, Yuji, Watanabe, Yuji, Tanaka, Akihiro, Araki, Hiroaki

“…Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to…”
Get full text

Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy by Toda, Haruka, Kawazoe, Hitoshi, Yano, Akiko, Yamamoto, Yuji, Watanabe, Yuji, Yamamoto, Yasunori, Hiasa, Yoichi, Yakushijin, Yoshihiro, Tanaka, Akihiro, Araki, Hiroaki

“…The therapeutic benefit of a three-drug combination of antiemetics has not been established in moderately emetogenic chemotherapy (MEC). The aim of this study…”
Get full text

Analysis of Clinical Factors and Mortality in Diffuse Large B-cell Lymphoma Patients Over or Under 80 Years of Age by Hasebe, Shinji, Tanaka, Keiko, Miyake, Yoshihiro, Asai, Hiroaki, Takeuchi, Kazuto, Fujii, Tomomi, Kawazoe, Hitoshi, Tanimoto, Kazushi, Yamanouchi, Jun, Azuma, Taichi, Yasukawa, Masaki, Yakushijin, Yoshihiro

“…The prognosis of diffuse large B-cell lymphoma (DLBCL) is remarkably improved after R-CHOP therapy. However, there are few detailed reports regarding very…”
Get full text